Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06140615 · ClinicalTrials.gov registry record · NA
Lung Ultrasound - Prospective Study
A NA study of Respiratory Distress of Newborn, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 2
- Study locations
NCT06140615: Active NA study of Respiratory Distress of Newborn, sponsored by University of Wisconsin, Madison.
NCT06140615 is a NA study of Respiratory Distress of Newborn that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06140615, a NA study of Respiratory Distress of Newborn, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to determine whether lung ultrasound can predict extubation success in neonates with respiratory distress. Participants will undergo a lung ultrasound pre- and post-extubation.
Primary Outcome
Correlate the lung ultrasound score to the success of extubation, which is defined as remaining extubated for \>72 hours. Ultrasound scores are measured on a 4-point scale (0=normal,3 = most abnormal).
Conditions Studied
Interventions
- DEVICE Ultrasound
Study Locations (2)
Minnesota
- University of Minnesota - Minneapolis
Wisconsin
- Unity-Point Health Meriter - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2023-12-11 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT06140615 still lists
NCT06140615 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Respiratory Distress of Newborn appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT06140615 reports a single indexed study location in Minnesota, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06140615 about?
NCT06140615 is a clinical study titled "Lung Ultrasound - Prospective Study". The goal of this clinical trial is to determine whether lung ultrasound can predict extubation success in neonates with respiratory distress. Participants will undergo a lung ultrasound pre- and post-extubation.
What is the current status of trial NCT06140615?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 71 participants. The study started on 2023-12-11. Estimated completion is 2026-06.
What conditions does trial NCT06140615 study?
This clinical trial studies the following conditions: Respiratory Distress of Newborn.
What interventions are being tested in trial NCT06140615?
The interventions under investigation include: Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT06140615?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06140615 being conducted?
This trial has 2 study locations across Minnesota, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Distress of Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06140615's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI